The pharmaceutical industry relies heavily on high-quality intermediates to synthesize advanced therapeutic agents. IDRA-21, a compound known for its potent nootropic effects, is increasingly recognized for its potential as a crucial pharmaceutical intermediate. Its unique properties, particularly in enhancing cognitive functions like learning and memory, make it a valuable substance for researchers and drug developers. As a professional IDRA-21 manufacturer, we focus on providing the quality and availability required by this demanding sector.
IDRA-21, with CAS number 22503-72-6, acts as a positive allosteric modulator of AMPA receptors, playing a significant role in synaptic plasticity. For its application as a pharmaceutical intermediate, consistent purity and well-defined specifications are paramount. We ensure our IDRA-21 consistently meets high purity standards, often exceeding 99%. This meticulous approach guarantees that downstream synthesis processes are reliable and that the final active pharmaceutical ingredients (APIs) will meet regulatory expectations. Researchers and companies seeking to buy IDRA-21 powder for intermediate use should prioritize suppliers who can provide certificates of analysis and detailed product documentation.
As a leading IDRA-21 supplier, we understand the critical nature of a secure and efficient supply chain. The availability of key intermediates can significantly impact drug development timelines. Our robust manufacturing capabilities, coupled with strategic planning, allow us to maintain a consistent supply of IDRA-21 for our clients. We are a reliable IDRA-21 manufacturer in China, capable of meeting both research-scale and larger commercial demands. When considering the IDRA-21 price, it’s important to factor in the reliability of supply and the assurance of quality.
For those looking to purchase IDRA-21 online for pharmaceutical development, selecting the right partner is crucial. We invite you to request a quote for IDRA-21 to discuss your specific project needs. Our commitment extends beyond just providing a product; we aim to be a supportive partner in your drug discovery and development journey. We ensure that our IDRA-21 meets the exacting standards required for its use as a pharmaceutical intermediate, thereby contributing to the advancement of new cognitive therapies.
In summary, IDRA-21 stands out as a valuable pharmaceutical intermediate with significant potential. By partnering with a reputable IDRA-21 manufacturer that prioritizes purity, quality, and supply chain reliability, organizations can accelerate their development processes and bring innovative treatments to market more effectively.
Manufacturing Facilities






Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.